Cartesian Therapeutics (RNAC) Interest Coverage Ratio Growth (1y) (2016 - 2023)
Cartesian Therapeutics (RNAC) Interest Coverage Ratio Growth (1y) (2016 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Cartesian Therapeutics |
261.84 Mn |
261.84 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
-414.76% |
| Jun 30, 2023 |
-227.86% |
| Mar 31, 2023 |
-249.29% |
| Dec 31, 2022 |
-283.55% |
| Sep 30, 2022 |
28.01% |
| Jun 30, 2022 |
2,949.22% |
| Mar 31, 2022 |
251.35% |
| Dec 31, 2021 |
151.78% |
| Sep 30, 2021 |
92.64% |
| Jun 30, 2021 |
100.80% |
| Mar 31, 2021 |
85.40% |
| Dec 31, 2020 |
70.48% |
| Sep 30, 2020 |
-23.79% |
| Jun 30, 2020 |
-96.71% |
| Mar 31, 2020 |
-130.28% |
| Dec 31, 2019 |
-101.55% |
| Sep 30, 2019 |
26.78% |
| Jun 30, 2019 |
21.07% |
| Mar 31, 2019 |
33.73% |
| Dec 31, 2018 |
175.21% |
